OncoSenX Company

OncoSenX is a developer of transient gene therapies designed for solid tumors.

Total Funding: 11700000
Headquarters: Seattle, Washington, United States
Employee Number: 1-10
Estimated Revenue: $10M to $50M
Last Funding Type: Seed
Investor Type: Seed
Last Funding Date: 2021
Investors Number: 8
Founded Date: 2017
Industry: Biotechnology, Health Care